Live feed07:27:55·595dANALYSTRatingvia QuantisnowRodman & Renshaw initiated coverage on Bicara Therapeutics with a new price targetByQuantisnow·Wall Street's wire, on your screen.BCAX· Bicara Therapeutics Inc.Health CareOriginal source